Buzz Stocks: Valeant Pharmaceuticals Intl Inc, Unilever plc (ADR), and TerraForm Global Inc

Today's stocks to watch in the news include Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Unilever plc (ADR) (NYSE:UL), and TerraForm Global Inc (NASDAQ:GLBL)

Jul 20, 2016 at 10:10 AM
facebook twitter linkedin


U.S. stocks are up after another round of strong earnings reports. Among equities in focus today are biotech Valeant Pharmaceuticals Intl Inc (NYSE:VRX), consumer goods stock Unilever plc (ADR) (NYSE:UL), and renewable energy stock TerraForm Global Inc (NASDAQ:GLBL).

  • VRX is up 5.1% at $24.74, after the Food and Drug Administration (FDA) approved the tablet form of Progenics Pharmaceuticals, Inc.'s (NASDAQ:PGNX) Relistor constipation treatment, to which VRX boasts exclusive development and commercialization rights. In addition, an FDA panel backed VRX's psoriasis drug, brodalumab, for FDA approval with a label warning of higher suicide risk, after six suicides that occurred during the drug's clinical trials. In addition, These are much-needed wins for the pharmaceutical stock, which has plunged nearly 90% year-over-year after a price gouging scandal and the ensuing backlash, with recent recovery attempts stalling at VRX's 50-day moving average -- a trendline set to be conquered today. Despite this, Valeant Pharmaceuticals Intl Inc has been a popular choice with bullish option players, with VRX's 50-day call/put volume ratio at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) of 2.02 sitting higher than 95% of all other readings from the past year. 
  • UL is up 0.1% at $47.03, after the firm agreed to purchase Dollar Shave Club LLC, a subscription-based personal grooming company, for a reported $1 billion. Unilever plc (ADR) is up 9% year-to-date, hitting an all-time high of $48.29 earlier this month. In spite of these promising results, short interest in the stock has ballooned 40.8% over the last reporting period, although shorted shares still only account for a measly 0.1% of UL's float. Option players have been more bearish than usual ahead of Unilever earnings tomorrow, with UL's 10-day ISE/CBOE/PHLX put/call volume ratio of 1.83 sitting in the 76th percentile of its annual range.

Don't miss the market's next move! Sign up now for Schaeffer's Midday Market Check

 

Stop leaving money on the table with the same old broken options trading approach...

There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

 
Schaeffer's Daily Bulletin Offer
 


 


 
Special Offers from Schaeffer's Trading Partners